Status:
UNKNOWN
ArTificial inTelligence-based RAdiogenomics in Colon Tumors
Lead Sponsor:
University of Roma La Sapienza
Collaborating Sponsors:
Associazione Italiana per la Ricerca sul Cancro
Conditions:
Colon Cancer Stage II
Colon Cancer Stage III
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this clinical trial is to develop an artificial intelligence-based model to assess radiogenomics signature of colon tumor in patients with stage II-III colon cancer. The main question it a...
Detailed Description
The ATTRACT trial consist of a retrospective and a prospective part. In the retrospective part of the trial, radiology, pathology, and genomics data of 300 patients with stage II-III colon cancer will...
Eligibility Criteria
Inclusion
- patients with pathologically proven stage II and stage III colon cancer;
- availability of a CT scan with portal-venous phase at the time of diagnosis;
- availability of immunohistochemical panel
Exclusion
- patients with no CT images prior to surgical resection;
- patients with CT scans characterized by motion artifacts preventing radiomics analysis
Key Trial Info
Start Date :
January 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06108310
Start Date
January 2 2021
End Date
December 31 2025
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Sant'Andrea
Roma, RM, Italy, 00189